C-Suite Awards: Aaron Black, Inova Translational Medicine Institute, Washington Business Journal

On the surface, the goals of personalized medicine, widely considered the future of medicine, are quite clear. Put patients into groups based on their genomic makeup, give doctors an edge in identifying potential threats, and shift from reactive to preventive treatment.  But collecting and analyzing the data that drives this industry is inherently complex, and Aaron…

Read More